Olivier Fitoussi

Attenuated immunochemotherapy regimen (R-miniCHOP) in elderly patients older than 80 years with diffuse large B-cell lymphoma: a multicentre, single-arm, phase 2 trial

Frédéric Peyrade, Fabrice Jardin, Catherine Thiéblemont et al. · The Lancet Oncology · 2011 · 545 citations

Medicine, Immunology, Oncology +15

Event-Free Survival at 24 Months Is a Robust End Point for Disease-Related Outcome in Diffuse Large B-Cell Lymphoma Treated With Immunochemotherapy

Matthew J. Maurer, Hervé Ghesquières, Jean‐Philippe Jais et al. · Journal of Clinical Oncology · 2014 · 410 citations · Full text

Medicine, Hematology, Oncology +17

Dose-dense rituximab-CHOP compared with standard rituximab-CHOP in elderly patients with diffuse large B-cell lymphoma (the LNH03-6B study): a randomised phase 3 trial

Richard Delarue, Hervé Tilly, Nicolas Mounier et al. · The Lancet Oncology · 2013 · 303 citations

Medicine, Oncology, Pharmacotherapy +4

A simplified scoring system in de novo follicular lymphoma treated initially with immunochemotherapy

Emmanuel Bachy, Matthew J. Maurer, Thomas M. Habermann et al. · Blood · 2018 · 206 citations · Full text

Medicine, Hematology, Oncology +9

High total metabolic tumor volume at baseline predicts survival independent of response to therapy

Laëtitia Vercellino, Anne‐Ségolène Cottereau, Olivier Casasnovas et al. · Blood · 2020 · 185 citations · Full text

Medicine, Cancer Biology, Oncology +12